| 000 | 01630 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517063921.0 | ||
| 264 | 0 | _c20160927 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a2326-6074 | ||
| 024 | 7 |
_a10.1158/2326-6066.CIR-15-0197 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Velasco, Guillermo | |
| 245 | 0 | 0 |
_aRadiologic Heterogeneity in Responses to Anti-PD-1/PD-L1 Therapy in Metastatic Renal Cell Carcinoma. _h[electronic resource] |
| 260 |
_bCancer immunology research _cJan 2016 |
||
| 300 |
_a12-7 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdiagnostic imaging |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 |
_aLung Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNivolumab |
| 650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRadiography |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKrajewski, Katherine M | |
| 700 | 1 | _aAlbiges, Laurence | |
| 700 | 1 | _aAwad, Mark M | |
| 700 | 1 | _aBellmunt, Joaquim | |
| 700 | 1 | _aHodi, F Stephen | |
| 700 | 1 | _aChoueiri, Toni K | |
| 773 | 0 |
_tCancer immunology research _gvol. 4 _gno. 1 _gp. 12-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/2326-6066.CIR-15-0197 _zAvailable from publisher's website |
| 999 |
_c25468893 _d25468893 |
||